We have located links that may give you full text access.
Comparative Study
Journal Article
Randomized Controlled Trial
Psychometric Comparison of the Full and Abbreviated Versions of the Dysfunctional Beliefs and Attitudes about Sleep Scale.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine 2016 June 16
STUDY OBJECTIVES: The different versions of the Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS) have limited comparison and summary of the findings across studies. We aimed to examine which version and which subscales had better psychometric properties.
METHODS: Data were derived from a randomized controlled trial of internet-based cognitive-behavioral therapy for insomnia (CBT-I) vs. waitlist in 312 participants with self-report diagnosis of insomnia disorder. The response distribution, internal consistency, construct and concurrent validity, and sensitivity to change were analyzed.
RESULTS: Floor or ceiling effects were found in 19 of the 30 DBAS items. Item-total correlation was < 0.30 in 43.3%, 31.3%, and 10.0% of the items in DBAS-30, DBAS-16, DBAS-10. Internal consistency was satisfactory for total scores, with Cronbach α ranging from 0.73-0.81, but 2 subscales of DBAS-30 and 1 subscale of DBAS-10 had Cronbach α < 0.35. Factor analysis produced 8, 4, and 3 factors for DBAS-30, DBAS-16, and DBAS-10. Only the factor structure of DBAS-16 was compatible with previous studies. Concurrent validity with insomnia, anxiety, and depressive symptoms was much stronger than with sleep diary parameters. Sensitivities to change of the DBAS scores following CBT-I and with sleep improvement were found, except the DBAS-30 "attributions" subscale and DBAS-16 "medication" subscale.
CONCLUSIONS: The DBAS-16 possesses better internal consistency, a reproducible factor structure, strong concurrent validity, and sensitivity to change, and therefore is recommended for research use. The DBAS-30 and DBAS-10 have their own strengths, but there are limitations in their application as a quantitative measure in research.
METHODS: Data were derived from a randomized controlled trial of internet-based cognitive-behavioral therapy for insomnia (CBT-I) vs. waitlist in 312 participants with self-report diagnosis of insomnia disorder. The response distribution, internal consistency, construct and concurrent validity, and sensitivity to change were analyzed.
RESULTS: Floor or ceiling effects were found in 19 of the 30 DBAS items. Item-total correlation was < 0.30 in 43.3%, 31.3%, and 10.0% of the items in DBAS-30, DBAS-16, DBAS-10. Internal consistency was satisfactory for total scores, with Cronbach α ranging from 0.73-0.81, but 2 subscales of DBAS-30 and 1 subscale of DBAS-10 had Cronbach α < 0.35. Factor analysis produced 8, 4, and 3 factors for DBAS-30, DBAS-16, and DBAS-10. Only the factor structure of DBAS-16 was compatible with previous studies. Concurrent validity with insomnia, anxiety, and depressive symptoms was much stronger than with sleep diary parameters. Sensitivities to change of the DBAS scores following CBT-I and with sleep improvement were found, except the DBAS-30 "attributions" subscale and DBAS-16 "medication" subscale.
CONCLUSIONS: The DBAS-16 possesses better internal consistency, a reproducible factor structure, strong concurrent validity, and sensitivity to change, and therefore is recommended for research use. The DBAS-30 and DBAS-10 have their own strengths, but there are limitations in their application as a quantitative measure in research.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app